semaglutide studies 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial Semaglutide - Research Peptide -

Studies that combined two or more antioxidant-based therapies as main intervention and clinical trials with no reported results were also excluded

AUD stigma is often ignored, leading to patients' denial and waiting too long to ask for help

Amlodipine rescues a patient with IOC due to primary hemochromatosis A 69-year-old man with a history of primary hemochromatosis (PH) (C282Y/H63D compound heterozygote) and myelodysplastic syndrome (MDS) presented with IOC leading to HF and conduction abnormalities

Knee kinematics (clinical measurements) demonstrated improvements in movement, knee mechanics and quality of life equivalent or better than published data for total knee replacement